Scientific Program


Friday, May 17th 2024

10:00 -10:15   Congress Opening

10:15 - 12:30 Plenary Session 1: Emerging trends in cancer-associated thrombosis (Part I)
Benjamin Brenner (Israel), Paolo Simioni (Italy)

Endothelial cell dysfunction in cancer: a modulator of CAT and metastasis?
Jamie O’Sullivan (Ireland)

Artificial Intelligence in CAT
Rushad Patell (USA)

The gut microbiome in cancer and thrombosis
Christoph Reinhardt (Germany)

Stroke in patients with cancer
Deborah Siegal (Canada)

Selected Abstract


12:30 -13:30 Debate: Do we need more complex and specific RAMs for CAT?
Chairs: Paolo Prandoni (Italy), Mario Mandalà (Italy)

YES: Andres Munoz-Martin (Spain)

NO: Ingrid Pabinger (Austria)


13:30 – 14:30  Lunch Sessions

14:30 – 15:00  Coffee


15:00 – 17:15 Plenary Session 2: Emerging trends in cancer-associated thrombosis (Part II)
Laurent Bertoletti (France), Francesco Dentali (Italy)

Trends and Updates on the Epidemiology of Cancer-Associated Thrombosis
Ang Li (USA)

Cancer immunotherapy in CAT
Claudine Graf (Germany)

Bleeding and thrombosis during CAR-T therapy
Elena Rossi (Italy)

Location of metastasis and complications of anticoagulant treatment
Maria Barca-Hernando (Spain)

Selected Abstracts


17:15 - 17:45  Coffee Break

17:45 – 18:45 Plenary Lecture: 8th Simon Karpatkin Memorial Lecture

The Conference Chairs

Introduction to Lecture:  Alok A. Khorana (USA)

VTE treatment in patients with cancer: Reflections on an evolving landscape
Agnes Y.Y. Lee (Canada)

Saturday, May 18th 2024

8:30 – 10:45 Plenary Session 3: Anticoagulation in hematological cancer patients
Chairs: Roberto Santi (Italy), Giancarlo Castaman (Italy)

VTE and mortality in patients with hematological malignancies
Kristen Sanfilippo (USA)

Management of CAT in thrombocytopenia: the uncertain balance between risks and benefits of platelet transfusion to support anticoagulation
Simon J. Stanworth (UK)

Pharmacological approach to increase platelet count: from ITP to chemotherapy-induced thrombocytopenia
Monica Carpenedo (Italy)

Selected Abstracts


10:45 – 11:15 Coffee break  


11:15 – 13:30 Plenary Session 4: Exploring the relationship between hemostasis and cancer: New insights
Chairs:  Erica De Candia (Italy), Hugo ten Cate (The Netherlands)

Platelets: A weapon against cancer
Paolo Gresele (Italy)

FXa inhibitors in cancer progression
Andrea Alimonti (Switzerland)

Coaguloma and tumor microenvironment
Janusz Rak (Canada)

Crosstalk between NETs and tumor progression
Laurence Panicot-Dubois (France)

Selected Abstracts

13:30 – 14:30           Lunch sessions

14:30 – 15:00           Coffee

15:00 – 17:00          Poster Discussion Sessions


17:00 – 18:15 Interactive session: Spotlight on prevention of VTE in cancer patients
Chair: Ajay K. Kakkar (UK)

A case of thrombosis in medical patient
Walter Ageno (Italy)

A case of thrombosis in surgical patient
Giancarlo Agnelli (Italy)

A case of thrombosis during anti-cancer drug treatment
Marina Elena Cazzaniga (Italy)

Discussant: Anna Falanga (Italy)


18:15 – 19:00 Special "Noble" Session
Chairs: Anna Falanga (Italy), Caterina Rizzi (Italy)

Patient and Public Involvement in CAT Research: Necessary or glorified tokenism?
Simon Noble (UK)

Sunday, May 19th 2024

8:30 – 10:15 Plenary Session 5: Past, present, and future of CAT - A Round Table Discussion
Chairs: Elvira Grandone (Italy), Alok A. Khorana (USA)

New drugs, old problems: Immune checkpoint inhibitors and CAT
Alok A. Khorana (USA)

Real-world Outcomes Data for DOAC vs LMWH vs other Anticoagulants: Promises and Pitfalls
Nicole Kuderer (USA)

FXI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis
Marcello Di Nisio (Italy)

General Discussion


10:15 – 11.45 Plenary session 6: Novel biomarkers for predicting clinical outcomes in cancer patients
Chairs: Marina Marchetti (Italy), Andrea Remuzzi (Italy)

Proteomics prediction of CAT and mechanistic insights
Jeffrey Zwicker (USA)

Age-related clonal hemopoiesis and thrombosis
Liran I. Shlush (Israel)

Machine Learning for the prediction of CAT
Simon Mantha (USA)

Selected Abstracts

11:45 - 12:45  Brunch

12:45 – 14:35 Plenary Session 7: Anticoagulation in cancer patients
Chairs: Anna Falanga (Italy), Roberto Labianca (Italy)

Risk of recurrent VTE in cancer patients after discontinuation of anticoagulant therapy
Gary E Raskob (USA)

Extended antithrombotic prophylaxis after cancer surgery
Cecilia Becattini (Italy)

Trends in the management of pediatric and adolescent patients with cancer-associated VTE
Gili Kenet (Israel)

Selected Abstracts


14:35 – 14:40  Concluding Remarks

Download the preliminary Scientific Program PDF